Antisense modulation of connective tissue growth factor expression
US6965025B2 · kind B2 · utility
134Cited by
6References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2001 |
| Grant date | Nov 15, 2005 |
| Priority date | — |
| Expiry date | Aug 6, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of connective tissue growth factor. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding connective tissue growth factor. Methods of using these compounds for modulation of connective tissue growth factor expression and for treatment of diseases associated with expression of connective tissue growth factor are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.